---
title: Grifols Partnership vs Siegfried Holding
slug_a: grifols
slug_b: siegfried
site: cdmo
review_signal_gate: closed
canonical_path: /compare/grifols/siegfried
---

# Grifols Partnership vs Siegfried Holding

Side-by-side profile data from each company listing on this directory.

## Grifols Partnership

- Profile: [/companies/grifols](/companies/grifols)

Grifols Partnership — CDMO specializing in small molecule injectable products, including concentrated and diluted parenteral formulations and intravenous solutions, leveraging 100+ years of Grifols expertise.

Services: 10. Modalities: 2. Indications: 5. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Other)

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials

## Siegfried Holding

- Profile: [/companies/siegfried](/companies/siegfried)

Siegfried Holding — Global CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.

Services: 18. Modalities: 2. Indications: 0. Locations: 6. Certifications: 4. The strongest documented coverage currently appears in services (18).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Viral Vector Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Oral Solid Dosage Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Ophthalmic Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Cold-Chain Storage & Logistics
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Gene Therapy

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Oral Solid Dose (OSD)
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- DEA licensed
- Hydrogenation
- Cryogenic (−80 °C)
- Flow Chemistry